Glucagon like peptide-1 receptor agonists (GLP-1RA) are widely used in the treatment of diabetes and obesity
II Cysteine The middle amino acid sulphur rate-limiting Cysteine carries the sulphur atom that becomes the thiol working surface of glutathione
The drug was originally developed for keeping Type 2 diabetes under control, but it was later approved by the FDA for weight loss as well
Parseghian CM, Patnana M, Bhosale P, Hess KR, Shih YT, Kim B, Kopetz S , Overman MJ, Varadhachary GR, Javle M, Naing A, Piha-Paul S, Hong D, Le H, Subbiah V, Pant S
Patients and clinicians alike should await full regulatory review and, where appropriate, NICE appraisal before drawing firm conclusions about its place in therapy
The final approval hearing was held on October 8, before U.S